In light of the rapidly evolving treatment landscape for neuromuscular diseases, we would like to discuss with you this year the possibilities we have and challenges we face measuring the outcome of our patients that benefit from such therapies. 

• What are relevant outcomes used in studies?
• Can we transfer them to our clinical practice and are they suitable for a day-to-day work?
• What are possible future perspectives?
• Colleagues from different medical specialities, professions, and also other Swiss reference centers have accepted to share their knowledge.

Coordination: Prof. O. Scheidegger, Prof. A. Klein, Prof. U. Fischer, Prof. P. Latzin

Full program and registration